Rising to the challenges in acute heart failure ( Grant funded Novartis)
-
Register
- User - Free!
*Supported by an educational grant from Novartis
This session is designed to equip clinicians with the skills to recognize and manage patients experiencing cardiogenic shock. Participants will review key diagnostic indicators, underlying pathophysiology, and evidence-based treatment strategies to guide timely and effective intervention.
*Due to rapidly changing clinical knowledge, once purchased, you have 90 days access to complete this education.
Credits: 1.0 Contact Hours; 1.00 are Pharmacology
This activity is designated for 1 AAPA Category 1 CME credits. Approval is valid from 1/1/2026 to 12/31/2026 . PAs should only claim credit commensurate with the extent of their participation.
Expiration Date: December 31, 2026
Free
LEARNING OBJECTIVES
After taking part in this educational activity, participants should be better able to:
-Define the etiology, incidence and prevalence of heart failure
-Differentiate the phenotypes of heart failure and AMI-CS
-Review key principles in patient identification and management
Linda Suplicki
RN, MSN, ACNP, CCRN
Linda Suplicki RN, MSN, ACNP, CCRN is an acute care nurse practitioner specializing in advanced heart failure and mechanical circulatory support. She brings with her over 25 years of experience in heart failure, mechanical circulatory support, and cardiogenic shock. She has both published and presented nationally on improving outcomes in patients requiring mechanical circulatory support and cardiogenic shock. She was instrumental in developing the first cardiogenic shock team in the state of New Jersey. Her passion for excellence in care has driven her to change the landscape of heart failure emphasizing the importance of developing best practices and utilizing a teams-based approach to improve quality outcomes.
CE/CME INFORMATION
Obtain Your Credits
To earn credits for this activity, navigate to the Content(s) tab and complete all course components in the following order: 1) watch the course presentation video; 2) complete the course evaluation; 3) pass the post-test with a score of 2/3 (66.7%) or higher. You may retake the post-test until a passing score is achieved, at which point you will be able to view/print a copy of your certificate of completion. This online certificate will also be saved within your profile 'My Courses/Certificates' -> 'Transcript/Certificates Earned' for future access.
Designation Statement
NPACE designates this educational activity for a maximum of 1.0 contact hours, of which 1.00 is pharmacology credit. Participants should claim only credit commensurate with the extent of their participation in the activity.
This activity is designated for 1 AAPA Category 1 CME credits. Approval is valid from 1/1/2026 to 12/31/2026 .
Accreditation Statement
Nurse Practitioner Associates for Continuing Education is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
This activity has been reviewed by the American Academy of Physician Associates Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME credits. Approval is valid from 1/1/2026 to 12/31/2026. PAs should only claim credit commensurate with the extent of their participation.
DISCLOSURES
Faculty
Contributing faculty, Linda Suplicki RN, MSN, ACNP, CCRN has disclosed:
Johnson & Johnson Employee, consultant, speaker Professional Eduation Impella
Planners
All planners and contributors involved in this educational activity have disclosed no relevant financial relationships.
Disclaimer
The material presented in this continuing education program is being made available for educational purposes only and is not intended to represent the best or only methods, medications and/or guidelines appropriate for the medical situation discussed. Rather the material is intended to present an approach, view, statement, or opinion of the presenter(s), which may be helpful, or of interest to other practitioners and should not be used by clinicians without the evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. NPACE disclaims any liability, loss, injury, or damage incurred as a consequence, directly or indirectly, of the use and application of any information given in a presentation.
Disclosure of Unlabeled Use
This educational activity may mention the uses of products that are not approved by the FDA for the indication(s) being discussed. The presenter(s) are instructed to notify participants when they are discussing unapproved uses or investigational agents. The opinions related to unapproved uses of products are solely those of the presenter(s) and are not endorsed or recommended by NPACE. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Commercial Support
There is no commercial support for this activity.
Key:
Complete
Next
Failed
Available
Locked
